Evoke Pharma Inc/ US30049G2030 /
17/05/2024 21:59:49 | Chg. -0.0049 | Volume | Bid01:23:08 | Ask01:23:08 | High | Low |
---|---|---|---|---|---|---|
0.4650USD | -1.04% | 31,434 Turnover: 9,033.3918 |
0.4224Bid Size: 2,500 | 0.5500Ask Size: 100 | 0.5000 | 0.4575 |
GlobeNewswire
16/05
Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care ...
GlobeNewswire
17/04
Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastropar...
GlobeNewswire
21/03
Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief ...
GlobeNewswire
07/03
Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024
GlobeNewswire
09/02
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
GlobeNewswire
14/11/2023
United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTI
GlobeNewswire
31/10/2023
Evoke Pharma & EVERSANA Unveil Cost Savings Real-World Data Demonstrating Meaningfully Reduced Healt...
GlobeNewswire
18/10/2023
Evoke Pharma’s Abstract Entitled “Superiority of Nasal Spray Compared to Orally Administered Metoclo...
GlobeNewswire
10/03/2022
Evoke Pharma Announces Key Opinion Leader Fireside Chat to Discuss Gastroparesis Treatment Landscape
GlobeNewswire
01/03/2022
Evoke Pharma to Report Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022
GlobeNewswire
02/02/2022
Evoke Pharma and EVERSANA Extend Commercialization Partnership to Further Support GIMOTI
GlobeNewswire
04/01/2022
Evoke Pharma to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference
GlobeNewswire
03/11/2021
Evoke Pharma to Report Third Quarter 2021 Financial Results on November 10, 2021
GlobeNewswire
20/10/2021
Evoke Pharma and EVERSANA Announce Positive Findings from GIMOTI® Market Research Study
GlobeNewswire
29/09/2021
Evoke Pharma’s Commercial Partner EVERSANA, Receives PM360’s Trailblazer Initiative Award for Innova...
GlobeNewswire
01/09/2021
Evoke Pharma to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference